For which of the following drugs would it be least important to measure plasma levels for the purpose of therapeutic drug monitoring?

For which of the following drugs would it be least important to measure plasma levels for the purpose of therapeutic drug monitoring?

• A. Warfarin
• B. Lithium
• C. Dabigatran
• D. Vancomycin

Answer: (C)

In therapeutic drug monitoring, you measure drug levels when there is wide variability between patients and a clear link between concentration and effect, especially with a narrow therapeutic window. Warfarin fits this because the anticoagulant effect (and bleeding risk) varies a lot, so monitoring with INR guides dosing. Lithium also has a very narrow therapeutic range, so regular plasma level checks are essential to avoid toxicity. Vancomycin requires trough levels or AUC-guided dosing to ensure efficacy while avoiding kidney injury. Dabigatran, however, is a direct oral anticoagulant with predictable pharmacokinetics and a fixed dosing regimen; routine plasma level measurement isn’t needed for standard therapy. Tests for dabigatran levels exist only in special situations (bleeding, renal impairment, planned urgent surgery), not for routine monitoring. That’s why dabigatran is the least important to measure plasma levels for therapeutic drug monitoring.

In therapeutic drug monitoring, you measure drug levels when there is wide variability between patients and a clear link between concentration and effect, especially with a narrow therapeutic window. Warfarin fits this because the anticoagulant effect (and bleeding risk) varies a lot, so monitoring with INR guides dosing. Lithium also has a very narrow therapeutic range, so regular plasma level checks are essential to avoid toxicity. Vancomycin requires trough levels or AUC-guided dosing to ensure efficacy while avoiding kidney injury. Dabigatran, however, is a direct oral anticoagulant with predictable pharmacokinetics and a fixed dosing regimen; routine plasma level measurement isn’t needed for standard therapy. Tests for dabigatran levels exist only in special situations (bleeding, renal impairment, planned urgent surgery), not for routine monitoring. That’s why dabigatran is the least important to measure plasma levels for therapeutic drug monitoring.